2021年最新SCI期刊影响因子查询系统
American Journal of Cardiovascular Drugs 期刊详细信息
基本信息
期刊名称 | American Journal of Cardiovascular Drugs American Journal of Cardiovascular Drugs |
---|---|
期刊ISSN | 1175-3277 |
期刊官方网站 | http://link.springer.com/journal/40256 |
是否OA | 否 |
出版商 | Adis International Ltd |
出版周期 | Bimonthly |
始发年份 | 2001 |
年文章数 | 48 |
最新影响因子 | 3.283(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学3区 | CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统4区 | 否 | 否 |
PHARMACOLOGY & PHARMACY 药学3区 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 2.12 | 0.903 | 0.819 |
Medicine Cardiology and Cardiovascular Medicine |
89 / 322 | 72% |
|||
Medicine Pharmacology (medical) |
92 / 232 | 60% |
补充信息
自引率 | 3.30% |
---|---|
H-index | 42 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | Submission to first decision 36 days |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1175-3277%5BISSN%5D |
投稿指南
期刊投稿网址 | https://www.editorialmanager.com/cvda/default.aspx |
---|---|
收稿范围 | The American Journal of Cardiovascular Drugs promotes rational therapy and effective patient management within the discipline of cardiology by providing a regular program of independent review articles covering all aspects of the management of cardiovascular disorders, particularly the place in therapy of newer and established agents and procedures. The journal includes: Short overviews of contentious or emerging issues (Current Opinions and Leading Articles, respectively). Comprehensive narrative reviews on therapeutic approaches to managing cardiovascular disease. Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. Therapy in practice reviews covering optimum management of specific conditions. Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in cardiovascular medicine. Original research articles reporting the results of well-designed clinical studies, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic studies. Additional enhanced features (including slide sets, videos and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in the American Journal of Cardiovascular Drugs may be accompanied by plain language summaries to assist readers in understanding important medical advances. All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication. |
收录体裁 | |
投稿指南 | |
投稿模板 | |
参考文献格式 | |
编辑信息 |